Evidence map›Paper›PMID 40573168›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer's Disease.

Israa J Hakeem, Hadil Alahdal, Hanadi M Baeissa, Tahani Bakhsh, Misbahuddin Rafeeq, Alaa Hamed Habib, Mohammed Matoog Karami, Maryam A Al-Ghamdi, Ghadeer Abdullah, Abeer Al Tuwaijri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Israa J HakeemDepartment of Biological Sciences, College of Science, University of Jeddah, Jeddah 23218, Saudi Arabia.ORCID 0000-0003-0759-2259
Hadil AlahdalDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11564, Saudi Arabia.ORCID 0000-0002-3075-5514
Hanadi M BaeissaDepartment of Biological Sciences, College of Science, University of Jeddah, Jeddah 23218, Saudi Arabia.ORCID 0000-0002-1029-8977
Tahani BakhshDepartment of Biological Sciences, College of Science, University of Jeddah, Jeddah 23218, Saudi Arabia.ORCID 0000-0002-3950-7218
Misbahuddin RafeeqFaculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-7219-9149
Alaa Hamed HabibFaculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-9198-7714
Mohammed Matoog KaramiDepartment of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-8943-0626
Maryam A Al-GhamdiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-0861-953X
Ghadeer AbdullahDepartment of Biology, Howard University, Washington, DC 20059, USA.
Abeer Al TuwaijriMedical Genomics Research Department, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs (MNGH), Riyadh 11426, Saudi Arabia.ORCID 0000-0002-7851-4365

Funding

Princess Nourah bint Abdulrahman University PNURSP2025R150
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseaseFDAMD simulationsmultitargeted dockingRebamipide

Identifiers

PMID40573168
PMCPMC12196254

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.